Latest Health News

Page 15 of 271
Patrys has formed an international Clinical Advisory Committee to help shape the next stages of RLS-2202, its injectable quetiapine candidate for delirium in acute-care settings. The appointments add recognised expertise in delirium research, intensive care and trial design, but do not yet provide clinical efficacy or regulatory evidence.
Ada Torres
Ada Torres
17 Sept 2026
WAM Global’s portfolio earnings grew 18% in FY2026, but valuation compression and currency losses left the investment portfolio down about 4.2% in Australian-dollar terms. The listed investment company declared a 13.2 cents per share fully franked full-year dividend, backed by a stated 5.2 years of dividend coverage.
Claire Turing
Claire Turing
16 Sept 2026
Medibank delivered higher FY26 operating profit, underlying earnings and dividends, while its health services arm posted strong growth after the Better Medical acquisition. The annual report also leaves investors weighing cybercrime litigation, capital flexibility and the pace of Medibank Health’s expansion.
Victor Sage
Victor Sage
16 Sept 2026
Lumos Diagnostics has increased live FebriDx sites to 215 and moved two additional top 100 US urgent care groups into network rollout across more than 40 sites. Two further health-system-owned groups are validating the test across more than 45 sites, but the announcement does not disclose contract values or guaranteed purchase volumes.
Victor Sage
Victor Sage
15 Sept 2026
CurveBeam AI has secured FDA 510(k) clearance for CT-based bone mineral density measurement, establishing the first regulatory step towards a potential new SaaS offering. The more commercially significant HiRise weight-bearing application still requires a separate clearance.
Victor Sage
Victor Sage
15 Sept 2026
PGG Wrightson delivered a sharp improvement in FY26 earnings, with Operating EBITDA up 15% to NZ$64.3 million and net profit rising 46% to NZ$15.6 million. The result supports a fully imputed 5.5 cents per share final dividend, although debt and GO-STOCK receivables have also expanded.
Ada Torres
Ada Torres
15 Sept 2026
Tivan has secured a 50 km² exploration concession immediately north of its Turiscai project in Timor-Leste, subject to formal regulatory grant. The addition would lift the project to eight licences covering approximately 394 km² ahead of planned maiden drilling in the fourth quarter.
Maxwell Dee
Maxwell Dee
14 Sept 2026
PT ANTAM (Persero) Tbk (ASX:ATM) reported Rp6.91 trillion in net profit and Rp62.71 trillion in first-half 2026 sales, with gold contributing the bulk of disclosed revenue. The Indonesian miner is also advancing downstream projects across gold, nickel and bauxite, although project costs and completion dates remain undisclosed.
Maxwell Dee
Maxwell Dee
14 Sept 2026
Kingfish’s adjusted NAV rose 1.2% in August, broadly matching the NZX benchmark as Vista, Fisher & Paykel Healthcare and Delegat delivered the strongest portfolio gains. The fund still trades at a 7.5% discount to NAV, while its one-year shareholder return remains negative.
Claire Turing
Claire Turing
11 Sept 2026
WasteCo is asking eligible New Zealand shareholders for up to NZ$750,000 in fresh equity as it tackles NZ$40.1 million of debt, a FY2026 loss and an aggressive operational reset. The non-underwritten plan follows a separate placement and is priced at NZ$0.007 per share.
Maxwell Dee
Maxwell Dee
11 Sept 2026
A multimillion-dollar, multiyear NIH grant will fund an expanded access program for Neurizon’s investigational NUZ-001, potentially giving up to 200 US patients access to the therapy for as long as 96 weeks. The program is designed to add long-term safety, survival and biomarker data alongside the pivotal HEALEY ALS trial.
Ada Torres
Ada Torres
9 Sept 2026
Elixinol Wellness has finalized the divestment of its US operations to Ananda Health, securing upfront and deferred payments totaling approximately A$465,000. This move refocuses the company on its Australian health and wellness portfolio while reducing exposure to US regulatory risks.
Victor Sage
Victor Sage
7 Sept 2026

Browse the archive

Full archive